181 related articles for article (PubMed ID: 6376219)
1. Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal.
Andrews WJ; Vasquez B; Nagulesparan M; Klimes I; Foley J; Unger R; Reaven GM
Diabetes; 1984 Jul; 33(7):634-42. PubMed ID: 6376219
[TBL] [Abstract][Full Text] [Related]
2. Insulin secretion and action in noninsulin-dependent diabetes mellitus. Is insulin resistance secondary to hypoinsulinemia?
Reaven GM; Chen YI; Coulston AM; Greenfield MS; Hollenbeck C; Lardinois C; Liu G; Schwartz H
Am J Med; 1983 Nov; 75(5B):85-93. PubMed ID: 6369971
[TBL] [Abstract][Full Text] [Related]
3. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
4. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
Henry RR; Brechtel G; Griver K
J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
[TBL] [Abstract][Full Text] [Related]
5. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
Reaven GM
Diabetes Care; 1984; 7 Suppl 1():17-24. PubMed ID: 6376025
[TBL] [Abstract][Full Text] [Related]
6. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
Markovic TP; Jenkins AB; Campbell LV; Furler SM; Kraegen EW; Chisholm DJ
Diabetes Care; 1998 May; 21(5):687-94. PubMed ID: 9589225
[TBL] [Abstract][Full Text] [Related]
7. Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics.
Hidaka H; Nagulesparan M; Klimes I; Clark R; Sasaki H; Aronoff SL; Vasquez B; Rubenstein AH; Unger RH
J Clin Endocrinol Metab; 1982 Feb; 54(2):217-22. PubMed ID: 7033272
[TBL] [Abstract][Full Text] [Related]
8. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
McMahon M; Marsh HM; Rizza RA
Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
[TBL] [Abstract][Full Text] [Related]
9. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.
Volk A; Renn W; Overkamp D; Mehnert B; Maerker E; Jacob S; Balletshofer B; Häring HU; Rett K
Exp Clin Endocrinol Diabetes; 1999; 107(2):140-7. PubMed ID: 10320055
[TBL] [Abstract][Full Text] [Related]
10. Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. Measurements of glucose transport and metabolism, insulin binding, and lipolysis in isolated adipocytes.
Foley JE; Kashiwagi A; Verso MA; Reaven G; Andrews J
J Clin Invest; 1983 Dec; 72(6):1901-9. PubMed ID: 6358258
[TBL] [Abstract][Full Text] [Related]
11. Postprandial oscillatory patterns of blood glucose and insulin in NIDDM. Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity.
Calles-Escandon J; Jaspan J; Robbins DC
Diabetes Care; 1989; 12(10):709-14. PubMed ID: 2693010
[TBL] [Abstract][Full Text] [Related]
12. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.
Scheen AJ; Paolisso G; Salvatore T; Lefèbvre PJ
Diabetes Care; 1991 Apr; 14(4):325-32. PubMed ID: 2060435
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction.
Gumbiner B; Van Cauter E; Beltz WF; Ditzler TM; Griver K; Polonsky KS; Henry RR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2061-8. PubMed ID: 8964829
[TBL] [Abstract][Full Text] [Related]
14. [Insulin resistance and insulin secretion in type II non-obese diabetics].
Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
[TBL] [Abstract][Full Text] [Related]
15. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
Frias JP; Yu JG; Kruszynska YT; Olefsky JM
Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
[TBL] [Abstract][Full Text] [Related]
16. The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and type 2 (non-insulin-dependent) diabetes mellitus.
Krotkiewski M; Lönnroth P; Mandroukas K; Wroblewski Z; Rebuffé-Scrive M; Holm G; Smith U; Björntorp P
Diabetologia; 1985 Dec; 28(12):881-90. PubMed ID: 3912243
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization.
Hollenbeck CB; Chen YD; Reaven GM
Diabetes; 1984 Jul; 33(7):622-6. PubMed ID: 6376218
[TBL] [Abstract][Full Text] [Related]
18. Improvement of glucose homeostasis after exercise training in non-insulin-dependent diabetes.
Reitman JS; Vasquez B; Klimes I; Nagulesparan M
Diabetes Care; 1984; 7(5):434-41. PubMed ID: 6389057
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
20. Is the insulin resistance of patients with noninsulin-dependent diabetes mellitus secondary to insulin deficiency?
Reaven GM; Chen YD; Moore JG; Hollenbeck CB
Horm Metab Res; 1986 Apr; 18(4):244-6. PubMed ID: 3519411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
